Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2004-09-03
2009-06-23
Rao, Deepak (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C544S323000
Reexamination Certificate
active
07550473
ABSTRACT:
Disclosed are novel compounds of formula (I):wherein R1, R2and R3are as defined herein, which are useful as inhibitors of PKC-theta and are thus useful for treating a variety of diseases and disorders that are mediated or sustained through the activity of PKC-theta, including immunological disorders and type II diabetes. This invention also relates to pharmaceutical compositions comprising these compounds, methods of using these compounds in the treatment of various diseases and disorders, processes for preparing these compounds and intermediates useful in these processes.
REFERENCES:
patent: 6432963 (2002-08-01), Hisamichi et al.
patent: 7173028 (2007-02-01), Dahmann et al.
patent: 2003/0171359 (2003-09-01), Dahmann et al.
patent: 2004/0029902 (2004-02-01), Singh et al.
patent: 2005/0038243 (2005-02-01), Singh et al.
patent: 1054004 (2000-11-01), None
patent: WO 97/19065 (1997-05-01), None
patent: WO 00/75113 (2000-12-01), None
patent: WO 01/00213 (2001-01-01), None
patent: 0164656 (2001-09-01), None
patent: 02064096 (2002-08-01), None
patent: WO 02/096887 (2002-12-01), None
patent: WO 02/096888 (2002-12-01), None
patent: 03032997 (2003-04-01), None
patent: WO 03/106451 (2003-12-01), None
patent: 2004067516 (2004-08-01), None
Ulrich, Chapter 4: Crystallization, Kirk-Othmer Encylopedia of Chemical Technology, Aug. 2002.
Vippagunta et al., Cyrstalline Solids, Advanced Drug Delivery Reviews, 48, pp. 3-26, 2001.
West, Solid Solutions, Solid State Chemistry and its applications, pp. 358 & 365, 1988.
Casanova et al., PubMed Abstract (Rev Neurol 28(9):909-15) May 1999.
International Search Report, Form PCT/ISA/210 for corresponding PCT/US2004/002240.
Cardozo Mario G.
Cogan Derek
Cywin Charles Lawrence
Dahmann George
DiSalvo Darren
Boehringer Ingelheim Pharma GmbH & Co. KG
Boehringer Ingelheim Pharmaceuticals Inc.
Datlow Philip I.
Devlin Mary-Ellen M.
Morris Michael P.
LandOfFree
Pyrimidine derivatives useful as inhibitors of PKC-theta does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pyrimidine derivatives useful as inhibitors of PKC-theta, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyrimidine derivatives useful as inhibitors of PKC-theta will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4107127